About Cognition Therapeutics, Inc. 
Cognition Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 5 Schemes (3.57%)
Foreign Institutions
Held by 7 Foreign Institutions (0.5%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
-5 Million
Pharmaceuticals & Biotechnology
USD 125 Million ()
NA (Loss Making)
NA
0.00%
-1.09
-76.61%
3.43






